Novartis AG

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 0.12%144.840.7%$945.77m
PFEPfizer Inc. 0.07%35.780.9%$901.81m
MRKMerck & Co., Inc. -1.27%82.090.7%$687.82m
ABBVAbbVie, Inc. -0.20%85.741.9%$655.41m
BMYBristol-Myers Squibb Co. 1.05%58.861.0%$620.36m
LLYEli Lilly & Co. -0.46%148.131.1%$558.48m
AZNAstraZeneca Plc 1.02%54.721.2%$248.15m
NVSNovartis AG 0.03%86.330.2%$163.80m
GSKGlaxoSmithKline Plc 0.36%37.520.2%$105.40m
PRNBPrincipia Biopharma, Inc. 0.02%99.970.0%$80.22m
NVONovo Nordisk A/S 0.44%68.570.1%$57.27m
SNYSanofi -0.96%50.300.2%$48.86m
RGENRepligen Corp. 1.65%142.257.1%$48.32m
RPRXRoyalty Pharma Plc 1.11%40.680.2%$47.16m
OPKOPKO Health, Inc. 0.81%3.1011.2%$44.06m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.